Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Upper Extremity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05113355
What this trial is testing

Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 3Neuroendocrine Carcinoma+1 more
Peking Union Medical College Hospital 23
Large-scale testing (Phase 3)Study completedNCT03664739
What this trial is testing

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

Who this might be right for
Acne Vulgaris
Bausch Health Americas, Inc. 608
Large-scale testing (Phase 3)Looking for participantsNCT05902169
What this trial is testing

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
CarThera 560
Testing effectiveness (Phase 2)Study completedNCT00066339
What this trial is testing

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Testing effectiveness (Phase 2)WithdrawnNCT06473974
What this trial is testing

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Who this might be right for
Facial Hyperpigmentation
Kayuraeffect, LLP
Early research (Phase 1)Study completedNCT06949124
What this trial is testing

Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

Who this might be right for
EndometriosisUterine FibroidsAssisted Reproduction
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT01048723
What this trial is testing

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 2
Early research (Phase 1)Ended earlyNCT04178460
What this trial is testing

Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Who this might be right for
Gastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more
Zai Lab (Shanghai) Co., Ltd. 60
Not applicableUnknownNCT05165459
What this trial is testing

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers

Who this might be right for
Venous Leg UlcerAutologous Adipose Stromal Vascular FractionAdipose-Derived Mesenchymal Stem Cells+1 more
Szeged University 10
Not applicableStudy completedNCT03471546
What this trial is testing

Early Palliative Care Intervention in Malignant Glioma

Who this might be right for
Malignant Glioma
Duke University 12
Not applicableLooking for participantsNCT05245812
What this trial is testing

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

Who this might be right for
Breast CancerHigh Risk of Breast Cancer
Deborah Farr, MD 90
Testing effectiveness (Phase 2)Study completedNCT05280067
What this trial is testing

ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES

Who this might be right for
Metastatic Breast Cancer in the Spine
Zetagen Therapeutics, Inc 10
Not applicableEnded earlyNCT01010334
What this trial is testing

Comparison of Standard of Care or Treatment on Protocol

Who this might be right for
Stomach CancerEsophageal CancerBladder Cancer+4 more
New Mexico Cancer Research Alliance 13
Testing effectiveness (Phase 2)Looking for participantsNCT07283692
What this trial is testing

Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)

Who this might be right for
Triple Negative Breast Cancer
RenJi Hospital 46
Not applicableStudy completedNCT07449611
What this trial is testing

Comparative Impacts of Two Anesthesia Methods on Peripheral Tissue Oxygenation in the Upper Limb

Who this might be right for
Regional AnesthesiaInterscalene BlocksShoulder Surgery+1 more
Sakarya University 50
Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Not applicableLooking for participantsNCT07133087
What this trial is testing

Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors

Who this might be right for
Breast Cancer Female
Halic University 42
Not applicableStudy completedNCT05689333
What this trial is testing

Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

Who this might be right for
Vitrectomy
VISTA Ophthalmics 32
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Large-scale testing (Phase 3)Looking for participantsNCT07059000
What this trial is testing

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Kedrion S.p.A. 40
Next Page